Anemia, Hypoalbuminemia, and Renal Impairment as Predictors of Bleeding Complications in Patients Receiving Anticoagulation Therapy for Nonvalvular Atrial Fibrillation: A Secondary Analysis

被引:29
作者
Abdelhafiz, Ahmed H. [1 ]
Myint, Min P. [2 ]
Tayek, John A. [3 ]
Wheeldon, Nigel M. [4 ]
机构
[1] Rotherham Gen Hosp, Dept Geriatr Med, Rotherham S60 2UD, S Yorkshire, England
[2] Sheffield Teaching Hosp, Sheffield, S Yorkshire, England
[3] Univ Calif Los Angeles, David Geffen Sch Med, Harbor UCLA Med Ctr, Los Angeles, CA 90095 USA
[4] No Gen Hosp, Dept Cardiovasc Med, S Yorkshire Cardiothorac Ctr, Sheffield S5 7AU, S Yorkshire, England
关键词
atrial fibrillation; anticoagulation; risk factors for bleeding; RISK; WARFARIN;
D O I
10.1016/j.clinthera.2009.07.015
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
Objective: The aim of this analysis was to evaluate the roles of anemia, hypoalbuminemia, and renal impairment as independent predictors of bleeding in patients with nonvalvular atrial fibrillation (NVAF) receiving anticoagulation therapy with warfarin. Methods: This was a previously published prospective, observational study conducted between November 1999 and July 2001. Patients with NVAF newly started on warfarin and referred to an anticoagulation clinic at a large university hospital (Northern General Hospital, Sheffield, United Kingdom), either at the time of hospital discharge or by their general practitioner, were eligible. Patients were divided into 2 groups: those aged <75 years; and those aged >= 75 years. Patients were seen at the clinic for an initial visit, and baseline information, including age, sex, employment status, medical history, and medication list, was obtained. Patients were also interviewed regarding episodes of bleeding (classified as minor bleeding events or major bleeding events) at the initial patient visit and by telephone every 4 to 6 weeks thereafter. Results: A total of 402 patients (mean [SD] age, 72.3 [10.3] years [range, 34-94 years]; 224 men [55.7%], 178 women [44.3%]) were included. Followup was complete for all patients (mean follow-up, 19.0 [8.1] months [range, 1.0-31.0 months]). A total of 107 minor and 11 major bleeding events were reported. Hypoalbuminemia was a significant predictor of all bleeding in patients aged <75 years (adjusted odds ratio [AOR] = 2.60; 95% CI, 1.26-5.33; P = 0.01), while renal impairment was a significant pre-dictor in patients aged >= 75 years (AOR = 2.65; 95% CI, 1.71-6.49; P = 0.01). After stratification by bleeding type, renal impairment was a significant predictor of major bleeding in patients aged >= 75 years (AOR = 2.93; 95% CI, 1.03-9.58; P = 0.001). Anemia was not associated with bleeding. Conclusion: Hypo albuminemia and renal impairment were identified as patient-related predictive factors for bleeding, whereas anemia did not appear to increase this risk. (Clin Ther. 2009;31:1534-1539) (C) 2009 Excerpta Medica Inc.
引用
收藏
页码:1534 / 1539
页数:6
相关论文
共 15 条
[1]   Results of an open-label, prospective study of anticoagulant therapy for atrial fibrillation in an outpatient anticoagulation clinic [J].
Abdelhafiz, AH ;
Wheeldon, NM .
CLINICAL THERAPEUTICS, 2004, 26 (09) :1470-1478
[2]   Risk factors for bleeding during anticoagulation of atrial fibrillation in older and younger patients in clinical practice [J].
Abdelhafiz, Ahmed H. ;
Wheeldon, Nigel M. .
AMERICAN JOURNAL OF GERIATRIC PHARMACOTHERAPY, 2008, 6 (01) :1-11
[3]  
[Anonymous], 1994, Arch Intern Med
[4]   Factors affecting bleeding risk during anticoagulant therapy in patients with atrial fibrillation: Observations from the Atrial Fibrillation Follow-up Investigation of Rhythm Management (AFFIRM) Study [J].
DiMarco, JP ;
Flaker, G ;
Waldo, AL ;
Corley, SD ;
Greene, HL ;
Safford, RE ;
Rosenfeld, LE ;
Mitrani, G ;
Nemeth, M .
AMERICAN HEART JOURNAL, 2005, 149 (04) :650-656
[5]   K/DOQI clinical practice guidelines for chronic kidney disease: Evaluation, classification, and stratification - Foreword [J].
Eknoyan, G ;
Levin, NW .
AMERICAN JOURNAL OF KIDNEY DISEASES, 2002, 39 (02) :S14-S266
[6]   The risk for and severity of bleeding complications in elderly patients treated with warfarin [J].
Fihn, SD ;
Callahan, CM ;
Martin, DC ;
McDonell, MB ;
Henikoff, JG ;
White, RH .
ANNALS OF INTERNAL MEDICINE, 1996, 124 (11) :970-+
[7]  
Hirsh J, 2008, CHEST, V134, P473
[8]  
Hirsh J, 2008, CHEST, V133, p110S, DOI 10.1378/chest.08-0652
[9]   THE EFFECTS OF DIETARY-PROTEIN RESTRICTION AND BLOOD-PRESSURE CONTROL ON THE PROGRESSION OF CHRONIC RENAL-DISEASE [J].
KLAHR, S ;
LEVEY, AS ;
BECK, GJ ;
CAGGIULA, AW ;
HUNSICKER, L ;
KUSEK, JW ;
STRIKER, G ;
BUCKALEW, V ;
BURKART, J ;
FURBERG, C ;
FELTS, J ;
MOORE, M ;
ROCCO, H ;
DOLECEK, T ;
WARREN, S ;
BEARDEN, B ;
STARKEY, C ;
HARVEY, J ;
POOLE, D ;
DAHLQUIST, S ;
DOROSHENKO, L ;
BRADHAM, K ;
WEST, D ;
AGOSTINO, J ;
COLE, L ;
BAKER, B ;
HAIRSTON, K ;
BURGOYNE, S ;
LAZARUS, J ;
STEINMAN, T ;
SEIFTER, J ;
DESMOND, M ;
FIORENZO, M ;
CHIAVACCI, A ;
METALIDES, T ;
KORZECRAMIREZ, D ;
GOULD, S ;
PICKETT, V ;
PORUSH, J ;
FAUBERT, P ;
SPITALEWITZ, S ;
FAUBERT, J ;
ZIMMER, G ;
SAUM, D ;
BLOCK, M ;
WOEL, J ;
ROSE, M ;
DENNIS, V ;
SCHWAB, S ;
MINDA, S .
NEW ENGLAND JOURNAL OF MEDICINE, 1994, 330 (13) :877-884
[10]   THE IMPACT OF LONG-TERM WARFARIN THERAPY ON QUALITY-OF-LIFE - EVIDENCE FROM A RANDOMIZED TRIAL [J].
LANCASTER, TR ;
SINGER, DE ;
SHEEHAN, MA ;
OERTEL, LB ;
MARAVENTANO, SW ;
HUGHES, RA ;
KISTLER, JP .
ARCHIVES OF INTERNAL MEDICINE, 1991, 151 (10) :1944-1949